Contraceptive consultations: A cross-sectional study of Norwegian women's experiences and opinions European Journal of Midwifery 1 Research paper Published by European Publishing. © 2019 Forsberg K.E. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non Commercial 4.0 International License. (http://creativecommons.org/licenses/by-nc/4.0) Kristin E. Forsberg1*, Ragnhild Lassemo1,2*, Mirjam Lukasse1,3 ABSTRACT INTRODUCTION Access to contraceptive consultations and the content of these consultations are important to achieve a safe and satisfying sexual life and successful reproduction when desired. The aim of this study was to investigate Norwegian women’s experiences of and opinions on contraceptive consultations. METHODS We conducted a cross-sectional study with a questionnaire distributed via Facebook with 1917 respondents of age ≥15 years. Descriptive analyses were used. RESULTS Few women found it hard to access consultations (5%). Across all age groups, side effects were the most common topic that women (69%) wanted more information about. Concern about side effects was also the most frequent reason given (27%) for not using hormonal contraceptives. Among women aged 25–34 years, 54% wanted to know more about different available contraceptives. The majority of women deemed issues of sexual wellbeing important to address during a contraceptive consultation. Few women reported that these topics had been raised. Just under half of the women found it appropriate to see a midwife for contraceptive/sexual health consultations. Only one-third knew that midwives can prescribe and administer long-acting reversible contraceptives (LARCs). CONCLUSIONS Women want contraceptive consultations to include more information on side effects and available hormonal contraceptives. Women want to be asked about their sexual health and wellbeing during contraceptive consultations. Women should be made aware that midwives can provide contraceptive services including LARCs. INTRODUCTION Reproductive health, sexual wellbeing and the use of contraceptives are closely linked. The United Nations (UN) states that reproductive health implies that people should be able to decide if and when they want to reproduce, and also that their sex life should be safe and satisfying1. The UN reports that 9% of married or in-union women worldwide use contraceptive pills, 14% use intrauterine contraceptive devices (IUDs), and 19% rely on female sterilization2. Short-term and reversible methods are more common in Africa and Europe, whereas long-acting and permanent methods are preferred in Asia and Northern America2. Among women of fertile age in Norway, 33% use h o rm o n a l c o n t r a c e p t i ve s o r n o n - h o rm o n a l I U D s 3. Approximately half of these women are using combined oral contraceptives (‘the pill’)4. The extent of the use of emergency contraceptives such as ‘the morning after pill’ or retrospect insertion of IUDs is not known in Norway. Sale statistics for ‘the morning after pill’ indicate that they add little to the total volume of contraceptives used5. There are a number of non-hormonal ways to limit the chances of pregnancy, such as: barrier methods, withdrawal method, breastfeeding, and ‘safe period’ during the menstrual cycle6. Sales of barrier devices are not registered and neither is AFFILIATION 1 Department of Nursing and Health Sciences, Faculty of Health and Social Sciences, University of South-Eastern Norway, Kongsberg, Norway 2 Akershus University Hospital, Nordbyhagen, Norway 3 Institute of Nursing and Health Promotion, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway *Contributed equally CORRESPONDENCE TO Mirjam Lukasse. Department of Nursing and Health Sciences, Faculty of Health and Social Sciences, University of South-Eastern Norway, 3603 Kongsberg, Norway. E-mail: mirjam.lukasse@usn.no ORCID ID: https://orcid.org/0000- 0002-9873-4023 KEYWORDS midwife, hormonal contraceptives, side effects, contraceptive consultations, sexual wellbeing Received: 19 December 2018 Revised: 22 May 2019 Accepted: 2 June 2019 Eur J Midwifery 2019;3(June):12 https://doi.org/10.18332/ejm/109773 Contraceptive consultations: A cross-sectional study of Norwegian women's experiences and opinions European Journal of Midwifery 2Eur J Midwifery 2019;3(June):12 https://doi.org/10.18332/ejm/109773 Research paper the use of natural family planning methods, nor did we find up-to-date research information on their use in Norway. The Norwegian government, in line with current research, recommends that more women should use Long-Acting Reversible Contraceptives (LARCs)7,8. The Pearl index, an index showing the number of unintended pregnancies while using any given contraceptive, is showing that LARCs are the best alternatives to avoid pregnancies. The index is based on how many out of 100 women conceive during a year of both typical and perfect use of a specific contraceptive. Imperfect use is low when the contraceptive is in situ, and not dependent on the user applying or digesting the contraceptive on frequent intervals. As an example, oral contraceptives have a Pearl index as low as 0.3 with perfect use, but as high as 8 with typical use. In comparison, the hormonal IUD has the same typical and perfect use index of 0.19. Except for the ‘morning after pill’, all hormonal contraceptives are provided through a contraceptive consultation. Easy access to a contraceptive consultation is thus important and essential. One aspect of this consultation is for the provider to ensure there is no predisposition for serious but rare side effects such as deep venous thrombosis, pulmonary thrombosis, myocardial infarction and cerebrovascular accidents10. However, less serious but more common side effects such as unplanned pregnancies due to poor compliance, altered bleeding patterns, genital dryness, mood changes, effects on mental health, changes of libido etc. should also be discussed, as they carry great importance with the women who have to live with these effects in their daily life10. There is limited research about Norwegian women’s o p i n i o n o n t h e a c c e s s t o a n d i n fo rm a t i o n a b o u t contraceptives. However, one large intervention study was conducted by SINTEF (The Foundation for Scientific and Industrial Research at the Norwegian Institute of Technology) among women aged 20–24 years in four Norwegian municipalities in the period 2008–0911. In two municipalities, women received free contraception and easy access to care, while women in two other municipalities received standard care. The number of women who used hormonal contraceptives did not differ between the groups10. However, in the intervention group there was a significant increase in the proportion of women using LARCs 10. Concern about side effects, reluctance to add hormones to the body, lack of information on side effects and suitable alternative contraceptives were all major barriers to more women using contraceptives 10. More recent studies involving all women of fertile age have not been conducted. Since the SINTEF study, the Norwegian government has implemented new guidelines encouraging the increased use of LARCs7,8. The effect these implementations have had on women’s experiences and opinions on contraceptive use and contraceptive counselling has not been examined. Besides the prescription of contraceptives and information about their side effects, the contraceptive consultation offers the opportunity for health care professionals to inquire about women’s sexual health and wellbeing. Neither the SINTEF study nor any other Norwegian study, that we have found, has investigated aspects of sexual health and wellbeing as part of the contraceptive consultation. However, we found one Swedish cross- sectional study by Wendt et al.12 of 448 women, which addressed these aspects in a gynecological consultation. This study showed that while few women had been asked, close to 92% of the women considered it appropriate and useful to be asked about sexual health and wellbeing during a gynecological consultation12. The aim of the present study was to investigate Norwegian women’s experiences of and opinions on contraceptive consultations. METHODS The Norwegian setting Norwegian youth aged 15–20 years have had access since 2002 to free consultations on sexual health and contraceptives through the public health clinic for youth or school health services. Here they can get prescriptions for free or subsidized contraceptives, including LARCs13. This service is offered mainly by public health nurses (PHNs) and some midwives, who have been authorized to prescribe hormonal contraceptives to women aged 16–20 years since 200214. Before this, prescriptions for contraceptives were only available from doctors, with a payable fee both for consultations and contraceptives. In 2016, the Norwegian government extended the right of midwives and PHNs to prescribe contraceptives to all women of fertile age, not only those 16–20 years of age8. This means that women can now choose to see a midwife or a PHN for their contraceptive needs. Most midwives and PHNs work at a public health clinic. Access to a contraceptive consultation has thus, in theory, become easier. However, due to lack of resources, in particularly midwives, most public health clinics still only offer appointments to women under the age of 20 years, and pregnant women, as required by the Norwegian law13,15. Other services are offered at each clinic’s discretion. Method, sample and design We conducted a cross-sectional study with a questionnaire distributed via the Internet. Data collection started on the 7 December 2017 and finished 28 February 2018. The survey was distributed with a link to Questback.com on Facebook pages such as sexogsamfunn.no, women’s groups, political organizations, and students’ organizations. Inclusion criteria were women who perceived themselves to be of fertile age, from 15 years of age with no upper age limit defined by the authors. All authors were involved in the development of the questionnaire. The full questionnaire is available as a supplementary file (Supplementary File 1). It was compiled by questions adapted from the SINTEF survey11 regarding access and information given during contraceptive consultations, and questions adapted from the Wendt et al.12 study regarding sexual wellbeing. The sociodemographic (independent) variables included were age, employment and European Journal of Midwifery 3Eur J Midwifery 2019;3(June):12 https://doi.org/10.18332/ejm/109773 Research paper size of municipality. To ensure anonymity, age was asked for in categories. The second section was about access and information on contraceptives. Women were asked how many times they had been to a consultation regarding contraceptives the previous year: none, 1–2 or ≥3. Participants currently not using hormonal contraceptives were asked if a different access would make them consider using them. All participants were asked how easy or difficult they found it to access consultations. Only women who had been to consultations regarding hormonal contraceptives were asked what topics they wanted more information on. If the participants had not used hormonal contraceptives in the last six months, they were asked why not. This question had 12 answering options and the women could tick off all relevant ones. In addition, women were asked if they had an unplanned pregnancy during the last year. The third section included questions on sexual wellbeing. Women were asked if questions on sexual wellbeing had been raised during contraceptive consultations they had attended, and whether they deemed the topic important or not. In the last section of the questionnaire participants were asked if they would find it appropriate to see a midwife regarding questions on contraceptives, sexual health and wellbeing, and if they were aware that midwives can administer IUDs and contraceptive implants. Finally, there was a section for free comments. Data analysis We performed descriptive statistical analysis; frequencies and proportions as well as cross-tabulation. The Statistical Package for Social Sciences (SPSS) version 24 for Windows was used to perform the analysis. Bivariate analysis was also performed, using a Pearson chi-squared test with 95% confidence intervals. There were little missing data, and missing values were not replaced. The cross tabulations by municipality and employment status showed no significance regarding the dependent variables. Therefore, bivariate analyses presented in the tables are performed with age groups and the dependent variables only. For analysis, age was recoded into three age groups: 15–24, 25–34 and ≥35 years. Answers to the question considering consultation access were recoded to binary results showing how many women found it hard to access consultations. Similarly, on whether women would use hormonal contraceptives if the service was different, answers were dichotomized to ‘yes’ with all other answers becoming ‘no’. Ethics NSD, Norwegian Centre for Research data, was consulted for initial approval, but application was not needed as total anonymity was ensured16. Information about the purpose of the survey and how the anonymity of the respondent was secured were stated in the introduction of the questionnaire (Supplementary File 1). Responding to the questionnaire was considered consenting to the use of the gathered data. We considered the possibility that painful emotions could be provoked due to the intimate nature of some of the questions. However, this was outweighed by the likely positive effect that women could become more aware that they can raise such issues next time they seek contraceptive counselling. The participants IP addresses were not accessible at any stage during the research. The data were stored at Questback.com and the results were sent by email as an SPSS data file. RESULTS A total of 1917 women responded to the questionnaire. Of all the women participating, 67% were under 35 years of age and 24% were students (Table 1). Among the age group 15–24 years, 63% were currently undertaking studies. Of all participants, 53% reported that they had been using hormonal contraceptives the last six months and 6% of the women had had an unplanned pregnancy the last year (Table 1). The youngest women (15–24 years) were the most frequent users of contraceptive consultations, with 63% seeing a health care professional at least once during the last year, compared to 33% of those ≥35 years (Table 2). Almost none of the women found it hard to get an appointment for a contraceptive consultation (Table 2). The majority of women across all age groups wanted more information about side effects, with no significant differences between the age groups. The women also expressed a need for more information on alternative available contraceptives. This was significantly more important for the women aged 15–34 years compared to those ≥35 years (Table 3). Variable n (%) Age 15–24 397 (20.7) 25–34 890 (46.4) ≥35 years 630 (32.9) Size of municipality by inhabitants >30000 1193 (62.3) 10000–30000 451 (23.6) <10000 271 (14.2) Missing 2 (0.1) Employment status Employed 1289 (67.4) Student 459 (23.9) Unemployed 48 (2.5) Other 116 (6.1) Missing 5 (0.2) Using hormonal contraceptives last 6 months 1028 (53.6) Unintended pregnancies last year 117 (6.1) Table 1. Characteristics of the participants (N=1917) European Journal of Midwifery 4Eur J Midwifery 2019;3(June):12 https://doi.org/10.18332/ejm/109773 Research paper The most common reason for not using hormonal contraceptives was concern about the side effects (Supplementary File 2). There were significant differences between the age groups regarding which topics of sexual health and wellbeing were deemed important to be raised in a contraceptive consultation (Table 4). For example, control over one’s sexuality and/or pleasure in sexual relationships is rated considerably more important by women less than 35 years compared to women 35 years and older (p<0.001). Item Age group Total pb 15–24 n (%) 25–34 n (%) ≥35 years n (%) n (%) Consultations last year (n=1910) None 144 (36.5) 488 (55.0) 423 (67.5) 1055 (55.2) <0.001 1–2 218 (55.2) 372 (41.9) 196 (31.3) 786 (41.0) <0.001 ≥3 33 (8.4) 28 (3.2) 8 (1.3) 69 (3.6) <0.001 Missing 2 (0.5) 2 (0.2) 3 (0.5) 7 (0.03) Access to consultations (n=1869) Find it hard to access 21 (5.3) 46 (5.2) 29 (4.8) 96 (5.0) 0.877 Easy/Neither easy nor hard 366 (94.6) 828 (94.7) 579 (95.2) 1773 (94.9) Missing 2 (0.5) 2 (0.2) 3 (0.5) 7 (0.03) Table 2. Frequency of and access to contraceptive consultations by age groupsa (N=1917) a Column percentages. b Chi-squared test for significance. Item Age group Total pb 15–24 n (%) 25–34 n (%) ≥35 years n (%) n (%) Available contraceptives 172 (50.7) 383 (54.2) 169 (39.2) 724 (49.0) <0.001 Side effects 239 (70.5) 467 (70.3) 283 (65.7) 1019 (69.0) 0.206 General information 196 (57.8) 317 (44.8) 170 (39.4) 683 (46.2) <0.001 Other subjects 37 (10.9) 59 (8.3) 44 (10.2) 140 (9.5) 0.343 Table 3. Wish for more information by women who had ever used hormonal contraceptivesa (N=1477) a Multiple choices available. b Chi-squared test for significance. Item Age group Total pb 15–24 n (%) 25–34 n (%) ≥35 years n (%) n (%) ‘How are you?’ Subject raised 156 (41.1) 313 (36.7) 222 (37.3) 691 (37.8) 0.325 Deemed important 306 (78.3) 677 (77.3) 451 (73.8) 1434 (76.4) 0.184 Control/pleasure in sexual relations Subject raised 82 (21.8) 125 (14.7) 78 (13.3) 285 (15.7) <0.001 Deemed important 279 (71.7) 572 (65.8) 348 (57.2) 1199 (64.3) <0.001 Body image/self-esteem Subject raised 38 (10.1) 84 (9.8) 56 (9.7) 178 (9.8) 0.977 Deemed important 256 (66.0) 564 (64.7) 345 (56.7) 1165 (62.3) <0.001 Genital discomfort or pain Subject raised 89 (23.5) 190 (22.2) 164 (28.1) 443 (24.4) 0.036 Deemed important 348 (89.5) 811 (92.9) 554 (91.0) 1713 (91.6) 0.105 Feeling of guilt or shame Subject raised 35 (9.2) 60 (7.1) 33 (5.6) 128 (7.1) 0.107 Deemed important 290 (74.7) 609 (70.2) 373 (61.6) 1272 (68.4) <0.001 Sexual abuse and/or violence Subject raised 55 (14.4) 77 (9.1) 51 (8.7) 183 (10.1) 0.006 Deemed important 339 (87.8) 731 (84.3) 469 (77.4) 1539 (82.2) <0.001 Table 4. Women’s opinions on questions regarding sexual health and wellbeing during contraceptive consultations (N=1829) a Chi-squared test for significance. European Journal of Midwifery 5Eur J Midwifery 2019;3(June):12 https://doi.org/10.18332/ejm/109773 Research paper Significant discrepancy was observed between whether the topics had been raised during the consultation or the women found it important that the topics were raised (Table 4). This applies to all the questions on sexual health and wellbeing (Table 4). Close to half of the women found it appropriate to see a midwife for contraceptive counselling or about issues concerning sexuality (Table 5). One-third knew that midwives could administer LARCs. There were no significant differences between the age groups (Table 5). DISCUSSION Very few women found access to contraceptive consultations to be an issue. Over two-thirds of all women wanted more information on side effects when attending contraceptive consultations. Insufficient information was also the main reason for non-use of hormonal contraceptives. All the different aspects of sexual wellbeing were deemed important to talk about during contraceptive consultations by over 50% of the women across all age groups. The women also indicated that the sexual wellbeing aspect of contraceptive care was under-communicated during these consultations. Almost half of the women found it appropriate to see a midwife for contraceptive/sexual health counselling. Only one-third knew that midwives can prescribe and administer long-acting reversible contraceptives (LARCs). Very few women in our survey found it hard to get an appointment for contraceptive consultation. The access to contraceptive consultations in Norway differs slightly from other comparable European countries. In the United Kingdom contraceptives are available from most general practices, specialist community contraception clinics, sexual health clinics, some genitourinary medicine clinics and pharmacies17. Swedish women mainly see midwives in community health clinics18 where they also get general care for their health and wellbeing. One could argue that the Norwegian setting, as described earlier, puts more limits on women’s access to contraceptive consultations. However, the women included in our study reported very little difficulty regarding access to contraceptive consultations. Across all age groups, women wanted more information about the side effects of contraceptives. The youngest women expressed a significantly higher need for general information on contraceptives compared to the other age groups. This increased need for general information among the youngest participants could be due to their lack of experience with contraceptive use, compared to the women of older age. Still, the youngest women in our study expressed a higher need for general information than the women in the SINTEF study where 42% of women wanted more general information11. The difference might be explained by increased focus in media on side effects, rising incidence of sexually transmitted infections19, and more focus on LARCs since the time of the SINTEF study. In our study, 53% of the participants had not used hormonal contraceptives the past year, slightly less than in the Norwegian national statistics3. The difference could be due to the fact that our study included a higher proportion of younger women. Concerns about side effects were given as the main specific reason for non-use in all age groups. This is in line with findings from other, international studies, which looked at reasons for contraceptive non-use among women20-22. Considering heavy news coverage of recent research on hormonal contraceptives increasing the incidence of depression and suicide23,24, it is reasonable to believe that women can be reluctant to use them. Women need to receive information on the rare but serious side effects of contraceptives. In addition, other more common but less serious side effects such as irregular bleeding, weight gain, mood changes, changes in libido etc. should be discussed with the women’s personal preferences and needs in mind. Bitzer et al.25 suggest a method of personalized interactive consultations that allow these individual needs to be addressed and also for the choice of contraceptive to be assessed and re-evaluated with regard to its effect on a woman’s biopsychosocial life25. In our sample, only a small proportion of the women had been asked questions on sexual wellbeing during contraceptive counselling, while a high proportion thought it to be important. The subjects of genital discomfort or pain, and history of sexual abuse or sexual violence, stood out as the topics that women of all age groups found most important to address in these consultations. Yet, very few had been asked about these issues. Compared to the findings of Wendt et al.12, women in our study were asked about these issues more often. There has been an increasing focus on sexual violence and abuse both internationally and in Norway over the past few years, with Item Age group Total pb 15–24 n (%) 25–34 n (%) ≥35 years n (%) n (%) ‘Would you consider it appropriate to see a midwife about contraceptive/sexual health needs?’ 172 (43.5) 410 (46.4) 303 (48.6) 885 (46.5) 0.282 ‘Did you know midwives can prescribe and administer LARC?’ 134 (33.8) 295 (33.4) 225 (36.1) 654 (34.4) 0.535 Table 5. Midwives as counsellors on contraceptive and sexual health issues (N=1902) a Chi-squared test for significance. European Journal of Midwifery 6Eur J Midwifery 2019;3(June):12 https://doi.org/10.18332/ejm/109773 Research paper a dedicated WHO directive26 and Norwegian governmental guidelines27. This might be an explanation for the increase. Unorganized movements such as #metoo are also currently raising awareness around women who have been subject to unwanted sexual attentions and abuse. This too might affect the views that women have on talking about their own experiences with a health care professional. The subject of ever having experienced sexual abuse or violence was broached with the women of the youngest age group more frequently than with the other groups, but rated as equally important by all women aged 15–34 years. Almost one in ten women in Norway has been subject to rape, and the likelihood of having experienced sexual abuse increases with every year lived28, making this a relevant subject across all age groups. It can be difficult for women to find a person they can confide in when experiencing problems with shame, body image, genital pain, control over their sexuality or similar issues. However, over half of the women across all age groups found all the subjects raised in the questionnaire important to talk about in a contraceptive consultation. It is easier to answer directly asked questions than to bring up subjects oneself. Therefore, it would be appropriate if health care personnel ask questions and invite open dialogue about the wider perspective on sexual health and wellbeing29. Contraceptive consultations offer an opportunity to discuss these issues. All women rated vaginal pain and discomfort important to talk about, but women 35 years and older were asked significantly more often. This might indicate that health care personnel consider it more appropriate to talk about this with women who have gone through childbirth with the accompanying trauma to the tissues. Similarly, women are more likely to start developing menopausal symptoms such as vaginal dryness and thinning of the mucous membranes after the age of 35 years. Younger and/or nulliparous women might be considered less likely to experience genital pain. However, the presumption that questions about vaginal pain and discomfort are more appropriate with increasing age is not accurate. Seventy-five per cent of all women who have vulvodynia (vaginismus, vulvar vestibulitis and generalized vulvar pain) experience the onset before the age of 34 years30, and up to 16% of women experience this pain syndrome31. Close to half of the women across all age groups considered midwives appropriate health care personnel to consult when they have questions about contraceptives or need advice on sexual health. We had expected fewer among the youngest women to give this answer, as less of them have yet met the midwife through community antenatal care. Only about one-third of the women were aware that midwives can prescribe and administer LARCs. This shows that there is a lack of knowledge among women about what services midwives can provide. Besides midwives being given the authority to prescribe, women need to be informed about their options and sufficient midwives need to be employed at community health centers. Limitations and strengths The questionnaire was electronic and spread via the internet, mainly through Facebook, so women needed access to the internet, a computer, and in many instances also a Facebook account, to participate. The questionnaire was in Norwegian only, requiring the women to being able to read and comprehend the language. This could lead to selection bias; thus our sample may not be representative for the Norwegian population in general. We did not ask about ethnicity and therefore do not know how many non- native Norwegian speakers participated. Overrepresented in our sample are women 20–39 years of age, with less respondents from age groups 15–19 and >45 years. This might be because the youngest women frequent Facebook less than other social media platforms, and that the older women felt the questionnaire did not apply to them. As the results are presented by age groups, it is easy to interpret the findings for the different age groups without generalizing to all women. It is uncertain whether anyone chose to answer multiple times, or if in fact all respondents were female. A strength of our study is that we have a large sample. Another strength is that we included questions previously used by experts in the field11,12, even though a couple of questions were modified. A weakness of our study is that the results are descriptive only, and no multivariate regression analyses were performed. However, these analyses should be used with caution in a cross-sectional study. CONCLUSIONS Access to contraceptive consultations was not a significant obstacle to contraceptive use. Women want consultations to include significantly more information on side effects and available alternative hormonal contraceptives. They also want information and communication about general sexual wellbeing such as vaginal pain and discomfort, and history of sexual violence and abuse. Just under half of the women view midwives as appropriate health care professionals to see on these matters. More focus needs to be placed on meeting the woman’s individual needs during the contraceptive consultation. Not only on the right type of contraceptive, but also her general sexual health and wellbeing. Women need to be made aware that midwives can provide contraceptive services, and midwives should consider initiating political action to be able to use their right to prescribe in the community. REFERENCES 1. The United Nations Population Fund. Sexual & reproductive health. https://www.unfpa.org/sexual- reproductive-health. Accessed December 15, 2018. 2. United Nations Department of Economic and Social Affairs, Population Division. Trends in Contraceptive Use Worldwide 2015. http://www.un.org/en/development/ d e s a / p o p u l a t i o n / p u b l i c a t i o n s / p d f / f a m i l y / trendsContraceptiveUse2015Report.pdf. Accessed December 19, 2018. European Journal of Midwifery 7Eur J Midwifery 2019;3(June):12 https://doi.org/10.18332/ejm/109773 Research paper 3. Folkehelseinstituttet. Dobling i bruk av p-stav blant unge kvinner. [Doubling in the use of p-stick among young women]. https://www.fhi.no/nyheter/2017/ dobling-i-bruk-av-p-stav-blant-unge-kvinner/. Published March 20, 2017. Updated March 21, 2017. Accessed December 15, 2018. 4. Lindh I, Skjeldestad FE, Gemzell-Danielsson K, et al. Contraceptive use in the Nordic countries. Acta Obstet Gynecol Scand. 2017;96(1):19-28. doi:10.1111/aogs.13055 5. Folkehelseinstituttet. Nødprevensjon. [Emergency c o n t r a c e p t i o n ] . h t t p s : / / w w w . f h i . n o / h n / legemiddelbruk/omsetning-utenom-apotek/stabilt- s a l g - a v - l e g e m i d l e r- i - d a g l i g v a re - fo r s t e - h a l v a r- 2018/#noedprevensjon. Published November 11, 2018. Accessed December 6, 2018. 6. Wo r l d H e a l t h O r g a n i z a t i o n . Fa m i l y p l a n n i n g / Contraception. https://www.who.int/news-room/ fact-sheets/detail/family-planning-contraception. Published February 8, 2018. Accessed April 2, 2019. 7. Helsedirektoratet. Spiral og p-stav (langtidsvirkende reversible prevensjon - LARC. https://helsedirektoratet. no/folkehelse/seksuell-helse/spiral-og-p-stav- langtidsvirkende-reversible-prevensjon-larc. Published 2017. Accessed March 29, 2018. 8. Helsedirektoratet. Utvidet rekvireringsrett til helsesøstre og jordmødre for prevensjonsmidler– Helsesøstre og jordmødres administrering av langtidsvirkende, reversibel prevensjon (LARC). https://helsedirektoratet. n o / L i s t s / P u b l i k a s j o n e r / A t t a c h m e n t s / 1 1 1 8 / Rundskriv%20rekvireringsrett%20og%20LARC%20IS- 13-2015.pdf. Published December 18, 2015. Accessed December 19, 2018. 9. ScienceDirect. Pearl Index. https://www.sciencedirect. com/topics/medicine-and-dentistry/pearl-index. Published 2019. Accessed May 22, 2019. 10. J o h a n s e n M . e M e t o d e b o k f o r s e k s u e l l h e l s e . [eMethodbook for sexual health]. https://emetodebok. no/. Accessed December 12, 2018. 11. Øren A, Leistad L, Haugan T. Endres prevensjonsvaner og abortrate hos kvinner 20-24 år ved tilbud om gratis hormonell prevensjon? http://www.sintef.no/ globalassets/upload/samfunn/a14751-gratis-p-pille. pdf. Published 2010. Accessed December 19, 2018. 12. Wendt E, Hildingh C, Lidell E, Westerståhl A, Baigi A, Marklund B. Young women's sexual health and their views on dialogue with health professionals. Acta Obstet Gynecol Scand. 2007;86(5):590-595. doi:510.1080/00016340701214035 13. Helsedirektoratet. Nasjonal faglig retningslinje for det helsefremmende og forebyggende arbeidet i helsestasjon, skolehelsetjeneste og helsestasjon for ungdom. [Health and school health services]. https:// helsedirektoratet.no/Retningslinjer/Helsestasjons-%20 og%20skolehelsetjenesten.pdf. Published 2017. Accessed December 19, 2018. 14. Helsedirektoratet. Utvidet rett til rekvirering av h o rm o n e l l e p re ve n s j o n s m i d l e r fo r h e l s e s ø s t re og jordmødre. https://jusboka.no/wp-content/ uploads/2016/01/IS-1575-Rapport-utvidet-rett- til-rekvirering-av-hormonelle-prevensjonsmidler-for- helsesostre-og-jordmodre.pdf?x22677. Published 2008. Accessed December 19, 2018. 15. Helse- og omsorgsdepartementet. Nasjonal faglig retningslinje for svangerskapsomsorgen. [Antenatal care]. https://helsedirektoratet.no/retningslinjer/ svangerskapsomsorgen. Published 2018. Accessed December 14, 2018. 16. Personvernombudet for forskning. Nettbaserte s p ø r r e u n d e r s ø k e l s e r. h t t p : / / w w w. n s d . u i b . n o / p e r s o n v e r n o m b u d / h j e l p / f o r s k n i n g s m e t o d e r / nettbaserte_sporreundersokelser.html. Published 2017. Accessed November 14, 2017. 17. B e l f i e l d T. P r i n c i p l e s o f c o n t r a c e p t i v e c a r e : choice, acceptability and access. Best Pract Res C l i n O b s t e t G y n a e c o l . 2 0 0 9 ; 2 3 ( 2 ) : 1 7 7 - 1 8 5 . doi:110.1016/j.ajog.2016.1008.1033 18. Intressegruppen för Mödrahälsovård inom SFOG Samordningsbarnmorskorna inom SBF i samarbete med Psykologer för mödrahälsovård och barnhälsovård. Mödrahälsovård, Sexuell och Reproduktiv Hälsa. https:// www.sfog.se/natupplaga/ARG76web4a328b70-0d76- 474e-840e-31f70a89eae9.pdf. Published 2008. Updated 2016. Accessed December 19, 2018. 19. Folkehelseinstituttet. Klamydia og lymfogranuloma venerum (LGV) i Norge 2015. https://www.fhi.no/ globalassets/dokumenterfiler/klamydia-og-lgv- arsrapport-2015.pdf. Accessed December 19, 2018. 20. Dixon SC, Herbert DL, Loxton D, Lucke JC. As many options as there are, there are just not enough for me: Contraceptive use and barriers to access among Australian women. Eur J Contracept Reprod Health Care. 2014;19(5):340-351. doi: 10.3109/13625187.2014.919380 21. Littlejohn KE. ‘It's those pills that are ruining me’: Gender and the Social Meanings of Hormonal Contraceptive Side Effects. Gend Soc. 2013;27(6):843- 863. doi:10.1177/0891243213504033 22. Higgins JA, Smith NK. The Sexual Acceptability of Contraception: Reviewing the Literature and Building a New Concept. J Sex Res. 2016;53(4-5):417-456. doi:410.1080/00224499.00222015.01134425 23. Skovlund CW, Mørch LS, Kessing LV, Lidegaard Ø. Association of Hormonal Contraception With Depression. JAMA Psych. 2016;73(11):1154-1162. doi:1110.1001/jamapsychiatry.2016.2387 24. Skovlund C, Mørch L, Kessing L, Lange T, Lidegaard Ø. Association of Hormonal Contraception With Suicide Attempts and Suicides. Am J of Psychiatry. 2018;175(4):336- 342. doi:10.1176/appi.ajp.2017.17060616 25. Bitzer J, Marin V, Lira J. Contraceptive counselling and care: a personalized interactive approach. Eur J Contracep Reprod Health Care. 2017;22(6):418-423. doi:10.1080/13625187.2017.1414793 26. World Health Organization, London School of Hygiene and Tropical Medicine. Preventing intimate partner and sexual violence against women: taking action European Journal of Midwifery 8Eur J Midwifery 2019;3(June):12 https://doi.org/10.18332/ejm/109773 Research paper and generating evidence. Geneva: Switzerland: World Health Organization; 2010. http://www. who.int/violence_injury_prevention/publications/ v i o l e n c e / 9 7 8 9 2 4 1 5 6 4 0 0 7 _ e n g . p d f. A c c e s s e d December 19, 2018. 27. Justis- og beredskapsdepartementet. Et liv uten vold: Handlingsplan mot vold i nære relasjoner 2014–2017. https://www.regjeringen.no/content assets/97cdeb59ffd44a9f820d5992d0fab9d5/ hplan-2014-2017_et-liv-uten-vold.pdf. Published 2014. Accessed December 19, 2018. 28. Nasjonalt kunnskapssenter om vold og traumatisk stress. Vold og voldtekt i Norge - En nasjonal forekomststudie av vold i et livsløpsperspektiv. https://www.nkvts.no/ content/uploads/2015/11/vold_og_voldtekt_i_norge. pdf. Published 2014. Accessed December 19, 2018. 29. H e l s e - o g o m s o r g s d e p a r t e m e n t e t . S n a k k o m det! Strategi for seksuell helse (2017–2022). https://www.regjeringen.no/cententassets/284e096 15fd04338a817e1160f4b10a7/strategi_seksuell_ helse.pdf. Published 2016. Accessed December 19, 2018. 30. Jantos M, Burns NR. Vulvodynia. Development of a psychosexual profile. J Reprod Med. 2007;52(1):63-71. https://www.ncbi.nlm.nih.gov/pubmed/17286072. Accessed December 19, 2018. 31. Sadownik LA. Etiology, diagnosis, and clinical management of vulvodynia. Int J Women's Health. 2014;6:437-449. doi:410.2147/IJWH.S37660 CONFLICTS OF INTEREST The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported. FUNDING There was no source of funding for this research. PROVENANCE AND PEER REVIEW Not commissioned; externally peer reviewed.